Cubist Pharmaceuticals Inc – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from 8-K 41 pages Cubist Pharmaceuticals, Inc. 1.125% Convertible Senior Notes Due 2018 1.875% Convertible Senior Notes Due 2020 Purchase Agreement

from 425 41 pages Cubist Pharmaceuticals, Inc. 1.125% Convertible Senior Notes Due 2018 1.875% Convertible Senior Notes Due 2020 Purchase Agreement

from SC 13D 5 pages Joint Filing Agreement

from SC 13D 5 pages Joint Filing Agreement

from 8-K 50 pages Cubist Pharmaceuticals, Inc. 2.50% Convertible Senior Notes Due 2017 Underwriting Agreement

from S-3ASR ~20 pages Underwriting agreement

from 8-K 24 pages 9,316,700 Shares Cubist Pharmaceuticals, Inc. Common Stock, $0.001 Par Value Underwriting Agreement

from SC 13G/A 1 page Joint Acquisition Statement

from 8-K ~20 pages Underwriting agreement

from SC 13G/A ~1 page Joint Acquisition Statement

from SC 13G ~1 page Joint Acquisition Statement

from S-3/A ~50 pages Underwriting agreement

from S-1 ~50 pages Proposed Form of Underwriting Agreement